Member Info for cmww2014

Agree Yeboha although If you've invested money in SNG but can't be a***d to watch an 8minute interview that's a worry.

The SPRINTER trial cost big money to run; that is finished. the ~25mln in the bank will last for plenty of time paying the odd statistician and buying paperclips.
They're looking for a platform trial which will be funded by others, the product/ devices are on the shelves and ready to go.
Money isn't the issue for SNG.
Getting that data to push for a platform trial or a scarcely thinkable EUA application is where we're at.

Interview is there to watch - RM said data in May.
Sub groups to be looked at are comorbidities and OAPs.
RM stressed a lot the wider applications of such a treatment and how it would be useful for seasonal flu or other viral lung infections.

Good spot Lauders.
It has been tough - cheers Rich !

https://www.transcrip-partners.com/respiratory

Something jumped out on their respiratory page near the bottom there are post-it notes that flip over to be examples of success.
One reads "Interpreting 'difficult' outcomes in clinical trials and steering discussions with the regulatory authorities" - the example continues "achieving additional indication for an inhaled COPD product"

Is it just me or does this sound familiar ?

Dunk, well said - I was just going back for the line of the RNS below:

With the strong safety profile that this treatment now has shown, it is appropriate for it to be considered by the large platform studies to confirm efficacy signals in severe COVID-19.

Did anyone else notice the NIH lady, Stacey Adam, is speaking at the ATS event ? - I seem to remember someone (manifesto?) emailing her on the progress of ACTIV-2 data?

Also there is mention of two companies Veramed and Transcrip with the SNG booking details on the ATS agenda - not sure I've seen these two mentioned before.

https://www.veramed.co.uk/
https://www.transcrip-partners.com/

I wonder if the word steroid gets muttered.
SNG and FARN could start an anti steroid with interferon campaign supported by DataMagik ?

Katie was saying she had a busy week with over 50 CEO interviews incl SNG/ RM.
No detail specific to SNG
Another two companies listed that I canny remember.

Synairgen are paying for the interview and the good press it generates so surely they have something worthwhile to say.

Katie is hardly going to grill Richard (and likely is given prepared discussion points or even scripted questions) so this 'should' be a cake walk for Mr Marsden.

Tweet has been deleted ?

This is tasty !
Wonder if Katie smiles at him in the same way now he's broke ;)
All jokes aside it will be good to hear what is in the pipeline.

Manifesto, the last weeks you've been saying results in March ?
I'm trying not to be negative but not sure what is achieved by making-up deadlines that can only lead to disappointment.

Profit for you is a decent trading session away woodie!
Average of 1.55 ish so it's a long old road back for me.
Will stick in but I've no intention of throwing more cash at it to average down.

I've lost enough for now, will probs move shares into the ISA that aren't already for the reasons you state but don't have your confidence to double down.
Best of luck.

In short I'd happily pay some CGT

I understand how it works, just don't think it has anything to do with the sp at this moment or these "contributors"
It also makes me a little sick to think of opening up my ISA account to witness the decimation, would much prefer a return to pre Monday levels and a cheque written for my CGT owed.

It's a lot of effort to expend for saving a bit in capital gains. Not sure I subscribe to that theory sd !
I also have filtered said distributors as their motives, although unknown, are tiresome.

Looking at history of changes ACTIV-3 seems to be the first to be reviewed in the month.
1st Oct
1st Nov
3rd Dec
5th Jan
4th March
Big leap to say any update will be the inclusion of SNG however

ACTIV-3 is the only one suitable for SNG is it not.

ACTIV-4 (blood thinners) - no
ACTIV-5 (proof of concept trial) - we're surely beyond this - no
ACTIV-6 (repurposed drugs) - no

Do US holders not need 5% ?